D-0140-2024 Class III Terminated
FDA drug recall D-0140-2024 was initiated by Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop on November 9, 2023 and is designated Class III. Reason for recall: Product Mix-up: Incorrect Product Formulation The recall status is terminated (terminated August 20, 2024). Affected quantity: 190 syringes.
Recall Details
- Product Type
- Drugs
- Report Date
- December 13, 2023
- Initiation Date
- November 9, 2023
- Termination Date
- August 20, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 190 syringes
Product Description
LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1
Reason for Recall
Product Mix-up: Incorrect Product Formulation
Distribution Pattern
USA Nationwide
Code Information
Lot#: 09202023@7, Exp 03/18/2024